Get Non-disclosure Agreement - Cardinal Health

Cardinal recorded a nearly $1 billion loss for the fiscal year that ended June 30, and projects expects sales to keep falling this year for its struggling medical supply division because of inflation, global supply restraints and falling demand for protective gear like masks.

Cardinal Health Inc. and more than a dozen of its directors have gotten final court approval of a $124 million settlement to resolve shareholders' derivative claims related to its distribution of opioids.

BOSTON – Ohio-based pharmaceutical distributor, Cardinal Health, Inc., has agreed to pay $13,125,000 to resolve allegations that it violated the False Claims Act by paying “upfront discounts” to its physician practice customers, in violation of the Anti-Kickback Statute.

“Cardinal Health thought it hit upon a surefire moneymaker by paying kickbacks to doctors, which cost health benefit programs millions of dollars in potentially fraudulent claims,” said Joseph R. Bonavolonta, Special Agent in Charge of the Federal Bureau of Investigation, Boston Division.

DEA investigation into diversion In 2008, Cardinal Health agreed to pay $34 million in civil penalties to settle DEA allegations that it failed to report suspicious orders of .

Cardinal Health Inc. and more than a dozen of its directors have gotten final court approval of a $124 million settlement to resolve shareholders' derivative claims related to its distribution of opioids.

“Cardinal Health recruited new customers by offering and paying cash bonuses in violation of the Anti-Kickback Statute and False Claims Act.

4 U.S. companies will pay $26 billion to settle claims they fueled the opioid crisis. Most of the funds from the settlement with manufacturers and distributors of opioids such as will go to health care and drug treatment programs designed to ease the opioid crisis.